Approval · Notice of Compliance 34827 · 2025
ARAVA: Notice of Compliance 34827
Issued February 12, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34827
- Date
- February 12, 2025
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARAVA | Not yet assigned | — |
Medicinal ingredients
- LEFLUNOMIDE 10 MG per TAB
- LEFLUNOMIDE 20 MG per TAB